Related by context. All words. (Click for frequent words.) 72 CIMZIA ™ 70 gemcitabine cisplatin 70 relapsed MM 70 FluCAM arm 69 FOLFOX4 69 Pemetrexed 69 salmeterol fluticasone 69 5-FU/LV 69 locoregional recurrence 68 sorafenib Nexavar 68 thalidomide Thalomid 68 ARCOXIA 68 gemcitabine carboplatin 68 oblimersen 68 invasive candidiasis 68 Pegylated Interferon 68 CYPHER Stent 68 stage IIIb IV 68 estramustine 68 squamous histology 68 ximelagatran 68 locoregional 67 idraparinux 67 Hycamtin ® 67 pegylated liposomal doxorubicin 67 Doxil ® 67 dacarbazine chemotherapy 67 CIMZIA TM certolizumab pegol 67 Navelbine ® 67 hepatorenal syndrome 67 posaconazole 67 intravesical therapy 67 concurrent chemoradiation 67 metastatic GIST 67 melphalan prednisone 67 sargramostim 67 NATRECOR R 67 complete cytogenetic response 67 comparator arm 67 DOXIL 67 bendamustine 67 recurrent glioblastoma multiforme 66 Adjuvant chemotherapy 66 achieved ACR# 66 placebo dexamethasone 66 aspirin clopidogrel 66 Platinol ® 66 pegylated interferons 66 cinacalcet 66 mitoxantrone plus 66 anthracycline taxane 66 chlorambucil 66 Amrubicin 66 prednisone prednisolone 66 sunitinib malate 66 infusional 5-FU/LV 66 riociguat 66 % CI #.#-#.# [003] 66 unresectable HCC 66 ARCALYST ® 66 malignant pleural mesothelioma 66 nondiabetic patients 66 Thal Dex 66 adriamycin 66 plus dexamethasone 66 metastatic malignant 66 cisplatin gemcitabine 66 5FU 66 postoperative chemotherapy 66 Toxicities 66 clodronate 66 chemoradiation therapy 66 certolizumab 66 Taxotere chemotherapy 66 Hormone Refractory Prostate Cancer 66 CANCIDAS 66 Cloretazine 66 Paraplatin ® 66 invasive aspergillosis 66 T1c 66 Elitek 66 EGFR mutation positive 66 paclitaxel Taxol ® 66 ACTEMRA TM 66 APTIVUS r 66 HeFH 66 oxaliplatin Eloxatin 66 Lung transplantation 65 lipid lowering agents 65 Mitoxantrone 65 oral diclofenac 65 gastrointestinal toxicities 65 Fludara 65 salmeterol fluticasone propionate 65 hypercholesterolaemia 65 YONDELIS 65 candidemia 65 HIV HCV coinfected 65 temsirolimus 65 MAGE A3 ASCI 65 Hazard Ratio 65 cytoreduction 65 radiotherapy RT 65 octreotide LAR 65 TMP SMX 65 Torisel 65 Peginterferon 65 tipranavir r 65 rFVIIa 65 microbiological eradication 65 recurrent metastatic 65 Zavesca R 65 Alkeran 65 DAS# CRP 65 NMIBC 65 Halaven 65 oxycodone CR 65 efaproxiral 65 Vidaza azacitidine 65 argatroban 65 plus gemcitabine 65 Temsirolimus 65 erlotinib Tarceva ® 65 Erlotinib 65 QTc prolongation 65 Onrigin 65 metastatic renal cell carcinoma 65 resected pancreatic cancer 65 gefitinib Iressa 65 fluorouracil 65 xanthine oxidase inhibitor 65 5-fluorouracil/leucovorin 65 KRAS mutations occur 65 SCIg 65 micafungin 65 fluvastatin 65 mycophenolate mofetil 65 budesonide foam 65 somatostatin analogues 65 Velcade bortezomib 65 Tarceva TM 65 thetreatment 65 demonstrated antitumor activity 65 NovoTTF 65 cytotoxic therapy 65 CIMZIA TM 65 liposomal amphotericin B 65 adalimumab Humira 65 Platinol ® cisplatin 65 LV dysfunction 65 Dacogen decitabine 65 4mg/kg 65 QVAR R 65 gadobutrol 65 GLIADEL R Wafer 65 mecasermin 65 pamidronate 65 ß blockers 65 TMC# r 65 ertapenem 65 cabazitaxel 65 colorectal adenoma 65 tenecteplase 65 evaluating tivozanib 65 intravenous bisphosphonates 64 hepatic metastases 64 recurrent NSCLC 64 dacarbazine DTIC 64 Moxifloxacin 64 metastatic malignant melanoma 64 standard chemotherapy regimen 64 PASI scores 64 caspofungin 64 deep venous thromboses 64 calcineurin inhibitors 64 mapatumumab 64 Engerix B 64 recurrent GBM 64 pancreatic insufficiency 64 TAXOTERE ® 64 galiximab 64 partial remissions 64 intravenous cyclophosphamide 64 PREZISTA r 64 pegylated interferon alfa 64 doxorubicin docetaxel 64 chemotherapy cisplatin 64 docetaxel Taxotere ® 64 lenalidomide dexamethasone 64 metaglidasen 64 allogeneic HSCT 64 Camptosar ® 64 thromboembolic complications 64 Mitomycin C 64 immunosuppressive regimen 64 titrated glipizide 64 FOLFIRI alone 64 CTAP# Capsules 64 Sanofi Aventis Taxotere 64 relapsed SCLC 64 β blockers 64 stage IIIB 64 metastatic carcinoid tumors 64 FluCAM 64 iniparib 64 morphometric vertebral fractures 64 debulking surgery 64 Safinamide 64 nadolol 64 moderately emetogenic 64 Fludarabine 64 FOLFIRI 64 MCyR 64 tigecycline 64 Helicobacter pylori eradication 64 INCB# [003] 64 briakinumab 64 Ixempra 64 CYT# potent vascular disrupting 64 taxane chemotherapy 64 carboplatin paclitaxel 64 mCRC patients 64 fluticasone salmeterol 64 Folfox 64 pegylated IFN 64 Xanafide 64 docetaxel Taxotere 64 etanercept Enbrel 64 Ceplene/IL-2 64 candesartan cilexetil 64 alemtuzumab treated 64 hypophosphatemia 64 biologic DMARD 64 LymphoStat B belimumab 64 tolerability profiles 64 Pegasys peginterferon alfa 2a 64 ATACAND 64 relapsing remitting MS RRMS 64 graft occlusion 64 unstable angina pectoris 64 alfuzosin 64 platelet inhibitor 64 Cimzia TM 64 Lenalidomide 64 regorafenib 64 metastatic gastric 64 gemcitabine Gemzar 64 chemoradiotherapy 64 boosted protease inhibitor 64 beclomethasone dipropionate 64 endocrine therapies 64 olmesartan 64 induced macular edema 64 benign prostatic hypertrophy BPH 64 IFN alfa 64 Non inferiority 64 advanced adenoma 64 enalapril 64 nodal metastasis 64 malignant neoplasm 64 relapsed ovarian cancer 64 Nesiritide 64 MabCampath 64 hematologic toxicity 64 oral allopurinol 64 steroid dexamethasone 64 FOLFIRINOX 64 platinum refractory 64 Nilotinib 64 trabectedin 64 HBeAg seroconversion 64 skeletal metastases 64 locoregional control 64 IV NSCLC 64 doripenem 64 forodesine 64 cediranib 64 anti angiogenic agents 63 gemcitabine chemotherapy 63 heavily pretreated 63 Ophena TM 63 YERVOY 63 follicular lymphoma FL 63 Taxotere ® 63 pT3 63 neutropaenia 63 genotypic resistance 63 Irinotecan 63 imipenem 63 VFEND 63 VELCADE melphalan 63 anthracyclines taxanes 63 completely resected 63 antiarrhythmic 63 NYHA Class II 63 Radical prostatectomy 63 FOLFOX6 63 acute coronary syndromes ACS 63 FROVA 63 endometrial hyperplasia 63 SPIRIVA ® 63 induce remission 63 neoadjuvant therapy 63 AGILECT R 63 Oral corticosteroids 63 Gleevec Glivec 63 Inhaled nitric oxide 63 overlapping toxicities 63 amifostine 63 mitoxantrone 63 K ras mutations 63 hypervascular tumors 63 Gliadel Wafer 63 CLL SLL 63 metastatic bone 63 Peginterferon alfa 2b 63 teriflunomide 63 plus prednisone 63 azacitidine 63 liposomal doxorubicin 63 ancrod 63 receptor tyrosine kinase inhibitor 63 Fludara ® 63 severe neutropenia 63 Nexavar sorafenib 63 basal bolus regimen 63 mcg QD 63 zoledronate 63 ara C 63 haematologic 63 iniparib BSI 63 FUSILEV enhances 63 Anthracycline 63 KRAS status 63 adjuvant radiotherapy 63 ® lenalidomide 63 APTIVUS 63 ALA PDT 63 mRCC 63 myelodysplastic myeloproliferative diseases 63 axitinib 63 dasatinib Sprycel 63 Femara letrozole 63 eribulin mesylate 63 idarubicin 63 Chronic lymphocytic leukemia 63 ketorolac 63 total thyroidectomy 63 protease inhibitor PI 63 MYCAMINE 63 methotrexate monotherapy 63 Retreatment 63 IXEMPRA 63 plus prednisone prednisolone 63 hormone refractory metastatic prostate 63 metastatic neuroendocrine tumors 63 flutamide 63 Surgical resection 63 Chronic HCV 63 locoregional disease 63 Patients Treated With 63 sunitinib Sutent 63 bezafibrate 63 tipranavir 63 pegylated interferon alfa 2b 63 rosuvastatin #mg 63 EXJADE 63 amrubicin 63 variceal hemorrhage 63 BARACLUDE ® 63 heavily pretreated patients 63 hA# 63 Intravitreal 63 PEGINTRON TM 63 metastatic RCC 63 ARIXTRA 63 colorectal liver metastases 63 bovine thrombin 63 XELOX 63 fluoropyrimidine 63 fluvoxamine Luvox 63 ARB telmisartan 63 nonsmall cell lung cancer 63 percutaneous vertebroplasty 63 Losartan 63 active comparator 63 invasive fungal infection 63 CAELYX 63 thrombocytopenic 63 oral clodronate 63 non squamous NSCLC 63 venous stasis ulcers 63 null responder 63 pCR 63 paclitaxel Taxol 63 Gemzar gemcitabine 63 interferon beta therapy 63 inhaled bronchodilators 63 unfractionated heparin UFH 63 adverse cytogenetics 63 PSA nadir 63 metastatic colorectal 63 AA Amyloidosis 63 Papillary 63 Zarnestra 63 elevated LDH 63 CTEPH 63 goserelin 63 Degarelix 63 stable angina 63 erlotinib Tarceva 63 vincristine doxorubicin 63 ZOLINZA 63 non valvular atrial 63 tipifarnib 63 dexamethasone Decadron 63 leukemia AML 63 Dasatinib 63 randomized multicenter Phase III 63 ALGRX 63 adenoma recurrence 63 AEGR 63 oral FTY# 63 essential thrombocythemia ET 63 Gleevec imatinib 63 aromatase inhibitors AIs 63 biliary tract cancer 63 Thalomid ® 63 abacavir Ziagen 63 PROSTVAC VF 63 basal cell carcinoma BCC 63 advanced hepatocellular carcinoma 63 recurrent DVT 63 doxorubicin cyclophosphamide 63 fibrate drugs 63 NATRECOR ® 63 SUPPRELIN R LA 63 binary restenosis 63 Adenomas 63 low dose cytarabine 63 antiemetics 63 PROSTVAC ® 63 ritonavir boosted 63 fallopian tube carcinoma 63 R0 resection 63 curative resection 63 IOP lowering 63 RhuDex ® 63 Taxotere docetaxel 63 PegIntron 63 ULORIC 63 rituximab Rituxan 63 paclitaxel poliglumex 63 portal vein thrombosis 63 trastuzumab Herceptin ® 63 lenalidomide Revlimid 63 nadroparin 63 pancreatic adenocarcinoma 63 PegIFN RBV 63 ovarian carcinoma 63 nonmetastatic 63 TEMODAL 63 Pazopanib 63 Cypher Stent 63 CYT# QbG# 63 refractory chronic lymphocytic 63 tamoxifen Nolvadex ® 63 daunorubicin 63 TYGACIL 63 intracranial hemorrhage ICH 63 TTF Therapy 63 fluorouracil leucovorin 63 MGd 63 ibandronate 63 malignant ascites 63 Genentech Rituxan 63 pegylated interferon alpha 62 antiarrhythmic drugs 62 pancreatic NET 62 ribavirin RBV 62 interferon ribavirin 62 hereditary deficiency 62 relapsed ALL 62 minimally symptomatic 62 Dabigatran 62 mTOR inhibitors 62 Bisphosphonate 62 EURIDIS 62 adjunctive placebo 62 antiangiogenic agents 62 fosamprenavir 62 colorectal carcinoma 62 radiation sensitizer 62 rizatriptan 62 Taxol ® 62 mg/m2 dose 62 receiving highly emetogenic 62 epithelial tumors 62 Nebulized 62 Stage IIB 62 HER2 positivity 62 Oropharyngeal Candidiasis 62 carboplatin chemotherapy 62 secondary hyperparathyroidism 62 paclitaxel carboplatin 62 liposomal formulation 62 elacytarabine 62 bevacizumab Avastin 62 lopinavir r arm 62 μg L 62 CR nPR 62 GP IIb IIIa inhibitors 62 hemorrhagic complications 62 neovascular diseases 62 Peg IFN 62 interferon alfa 62 radiochemotherapy 62 antiarrhythmic drug 62 PREZISTA rtv 62 sleeve lobectomy 62 INVEGA ® 62 OvaRex ® MAb 62 Noxafil 62 Hepatocellular Carcinoma HCC 62 clevidipine 62 bortezomib Velcade 62 Taxol paclitaxel 62 Ozarelix 62 olanzapine LAI 62 metastatic castration resistant 62 Alocrest 62 sorafenib Nexavar ® 62 plus aztreonam 62 severe exacerbations 62 Neulasta ® 62 invasive carcinomas 62 Flu Cy 62 receiving prophylactic anticoagulation 62 arterial thromboembolic events 62 oral antidiabetic medication 62 STRIDE PD 62 PROCRIT ® 62 topotecan 62 Topotecan 62 symptomatic paroxysmal AF 62 cardiotoxic 62 Aplidin 62 NAVISTAR R 62 daily subcutaneous injections 62 primary patency 62 cidofovir 62 differentiated thyroid 62 HBeAg negative 62 dasatinib Sprycel ® 62 Hodgkin lymphoma HL 62 Gemzar ® 62 immunomodulatory therapy 62 lanthanum carbonate 62 Xelox 62 median survivals 62 HuMax EGFr 62 TAXUS Express Stent 62 psoriatic arthritis PsA 62 Interferon alfa 62 underwent surgical resection 62 NEVO ™ 62 atorvastatin #mg 62 glycated hemoglobin levels 62 surgical debulking 62 relapsed multiple myeloma 62 dose atorvastatin 62 peripheral sensory neuropathy 62 symptomatic VTE 62 ribavirin therapy 62 IFN beta 62 HBeAg + 62 trans retinoic acid ATRA 62 tumor xenograft models 62 aflibercept VEGF Trap 62 Xeloda ® 62 homozygous familial hypercholesterolemia 62 anthracycline chemotherapy 62 prospectively stratified 62 TO AVOID PREGNANCY WHILE 62 HBeAg positive 62 lenalidomide Revlimid R 62 EndoTAGTM 1 62 CIN2 + 62 refractory metastatic 62 prednisone prednisolone plus 62 refractory gout 62 Navelbine 62 Vernakalant 62 Sezary syndrome 62 esophageal candidiasis 62 antithrombotic therapy 62 HoFH 62 vandetanib 62 efalizumab 62 Gleevec imatinib mesylate 62 Oxaliplatin 62 Bezielle 62 zalutumumab 62 elotuzumab 62 unresectable stage 62 bevacizumab Avastin ® 62 Hypotension 62 hemorrhagic cystitis 62 refractory NSCLC 62 Aliskiren 62 GnRH agonists 62 preoperative chemotherapy 62 FOR FURTHER INFORMATION ABOUT 62 ethambutol 62 Kepivance 62 anti arrhythmic drug 62 metastatic bladder 62 mutated KRAS 62 dose cytarabine 62 doublet chemotherapy 62 malignant neoplasms 62 Golimumab 62 underwent resection 62 tumor lysis syndrome 62 biochemical relapse 62 liver transplant recipients 62 hepatocellular carcinomas 62 MGUS 62 eosinophilic asthma 62 smoldering multiple myeloma 62 epoprostenol 62 Bevacizumab Avastin 62 8mg/kg 62 Gefitinib 62 ELOXATIN 62 HNSCC 62 STELARA ™ 62 refractory ovarian cancer 62 atrophic gastritis 62 gastrointestinal tolerability 62 phase IIb trial 62 dyslipidaemia 62 cisplatin chemotherapy 62 Zorbtive TM 62 adjuvant tamoxifen 62 docetaxel chemotherapy 62 superficial bladder cancer 62 anticoagulant warfarin 62 Etoposide 62 Telatinib 62 VAPRISOL 62 ritonavir boosted lopinavir 62 oral rivaroxaban 62 #mg dose [002] 62 Bevacizumab 62 ZACTIMA 62 clinically localized prostate 62 cariprazine 62 mcg BID 62 histological subtype 62 HBeAg negative patients 62 anagrelide 62 baseline LDH 62 vinorelbine tartrate 62 echocardiographic parameters 62 dacarbazine 62 Operative mortality 62 Prolongs Survival 62 R Saizen R 62 aldosterone antagonists 62 achieved CCyR 62 histologic subtype 62 renal toxicity 62 metastatic renal 62 antitumor effect 62 cytoreductive surgery 62 Aflibercept 62 rosuvastatin Crestor 62 thromboprophylaxis 62 XIENCE V PROMUS Stent 62 nicardipine 62 herpetic keratitis 62 Aloxi injection 62 A1PI 62 Daclizumab 62 alpha interferons 62 Zemplar 62 Mg Usa 62 metastatic CRC 62 eflornithine 62 ixabepilone 62 zotarolimus 62 cisplatin vinorelbine 62 stage IIIB IV 62 canakinumab 62 BEXXAR Therapeutic Regimen 62 HCV RESPOND 2 62 chemotherapeutic regimens 62 Roche Xeloda 62 Fluorouracil 62 efavirenz EFV 62 VaD 62 DEFLUX 62 conventional DMARDs 62 Rituxan rituximab 62 TNF antagonist 62 macroalbuminuria 62 TAXOTERE R 62 severe hypersensitivity reactions 62 HBeAg 62 SPRYCEL ® 62 panitumumab Vectibix 62 deferiprone 62 5 Fluorouracil 62 intra arterial chemotherapy 62 HBeAg positive patients 62 bronchial hyperresponsiveness 62 metformin monotherapy 62 miconazole Lauriad ® 62 relapsed CLL 62 PLX STROKE targeting 62 Tamibarotene 62 pertuzumab 62 Combination therapy 62 corticosteroid dexamethasone 62 gastric adenocarcinoma 62 plasma kallikrein inhibitor 62 pomalidomide 62 ACUITY trial 62 pooled comparator 62 symptomatic intracranial hemorrhage 62 Tasimelteon 62 polyp recurrence 62 vinorelbine 62 hepatic enzymes 62 chronic HBV 62 pT2 62 elevated triglyceride levels 62 Cipralex ® 62 virologic breakthrough 62 PHPT 62 APTIVUS R 62 complement inhibitor eculizumab 62 TORISEL 62 radioiodine therapy 62 tumor necrosis 61 abiraterone acetate 61 refractory metastatic colorectal cancer 61 taxane refractory 61 ACE Inhibitors 61 somatostatin analog 61 BRAF inhibitor 61 CsA 61 drug Treanda 61 EDEMA3 trial 61 gp# vaccine 61 cetuximab Erbitux 61 recurrent glioblastoma 61 stratifying patients 61 Fulvestrant 61 acetonide FA 61 refractory AML 61 Raptiva ® 61 PREZISTA ritonavir 61 macrolide antibiotic 61 reduce serum phosphate 61 Yondelis ® 61 unresectable 61 papillary renal cell carcinoma 61 thromboembolic events 61 cyclophosphamide doxorubicin vincristine 61 PREZISTA r arm 61 Gleevec resistant 61 bladder carcinoma 61 denileukin diftitox 61 oral olanzapine 61 transaminase elevations 61 dose cohort 61 Hycamtin 61 Allovectin 7 ® 61 amphotericin B 61 nitroprusside 61 OMNARIS HFA 61 NMDA antagonists 61 beta lactam antibiotic 61 tolterodine ER 61 receiving VELCADE 61 Intravitreal injections 61 Squamous 61 pancreatic neuroendocrine tumors 61 FIRMAGON 61 H. pylori eradication 61 ADPKD 61 iodixanol 61 prucalopride 61 ceftazidime 61 recurrent VTE 61 CCyR 61 Topical corticosteroids 61 CP CPPS 61 ABVD 61 ritonavir boosted atazanavir 61 neoadjuvant treatment 61 PAOD 61 Lamotrigine 61 cGy 61 antimetabolite 61 FASLODEX 61 median PFS 61 non resectable metastatic 61 Natalizumab 61 definite stent thrombosis 61 Pertuzumab 61 trials RCTs 61 mTOR inhibitor 61 LEXIVA r 61 Patients Receiving 61 #mg BID [001] 61 pemetrexed 61 Increlex R 61 angiotensin converting enzyme inhibitors 61 MACCE 61 mesalamine granules 61 Median progression 61 histologically confirmed 61 postoperative complication 61 QVAR ® 61 interferon alfa 2b 61 ZACTIMA TM ZD# 61 NeuroStar TMS Therapy 61 angiographic restenosis 61 KRAS mutant tumors 61 RLAI 61 anti leukemic 61 monoclonal antibody conjugated 61 autoantibody positive 61 EDSS scores 61 dopamine partial agonist 61 Subgroup analysis 61 perioperative morbidity 61 edifoligide 61 Trabectedin 61 beta blocker therapy 61 Pegylated Liposomal Doxorubicin 61 osteoporotic vertebral compression fractures 61 grade cervical intraepithelial 61 S/GSK# 61 Paraplatin ® carboplatin 61 renal cell carcinomas 61 pemphigus vulgaris 61 moderate renal impairment 61 VIDAZA 61 SNRI 61 Median PFS 61 chronic GVHD 61 liver metastasis 61 cancer mCRC 61 Vandetanib 61 PEGylated anti 61 renal artery stenting 61 Procoralan 61 trospium 61 pharmacokinetic equivalence 61 Advanced Renal Cell 61 Faslodex 61 either acutely decompensated 61 Arranon 61 SNT-MC#/idebenone 61 IMiDs ® compound 61 variceal bleeding 61 overactive bladder syndrome 61 Vfend 61 paricalcitol 61 TPV r 61 Tiotropium 61 PROSTVAC TM 61 TheraCIM 61 tacrolimus ointment 61 Lipitor #mg 61 TAVR 61 Cholinesterase Inhibitors 61 FOLPI 61 Tumor Response 61 refractory CLL 61 metastatic HRPC 61 mg Proellex 61 ACZ# 61 pharmacologically active isomer 61 osteoporotic vertebral fractures 61 distant metastasis 61 urate lowering 61 MYLOTARG 61 seminoma 61 CALGB # [002] 61 Pharmacokinetic parameters 61 GW# [003] 61 piperacillin tazobactam 61 receiving INTRON 61 relapsed myeloma 61 BENICAR HCT 61 antiandrogen 61 Tarceva erlotinib 61 % CI #.#-#.# [008] 61 dalteparin 61 splenectomized 61 finasteride Proscar 61 Vascugel ® 61 antiepileptics 61 neurologic progression 61 trans retinoic acid 61 stage IIIb 61 bexarotene 61 beta 1a 61 Starlix 61 low dose Iluvien 61 quinolone 61 Known hypersensitivity 61 recurrent genital herpes 61 segment binary restenosis 61 IV bisphosphonates 61 MYDICAR ® 61 Abbokinase 61 CINQUIL 61 dexrazoxane 61 NSTE ACS 61 sirolimus eluting stent 61 Copegus ribavirin 61 Tipranavir 61 Levetiracetam 61 MADRS score 61 venlafaxine XR 61 revascularizations 61 benazepril 61 tapentadol ER 61 HER2 overexpression 61 antiretroviral naïve 61 anemia neutropenia 61 Valopicitabine 61 chemoembolization 61 labetalol 61 non metastatic osteosarcoma 61 Pegylated interferon 61 ELACYT 61 remission induction 61 ALT elevation 61 urothelial carcinoma 61 5 FU leucovorin 61 pediatric malignancies 61 antithrombotics 61 Naive Patients 61 interstitial brachytherapy 61 Campath alemtuzumab 61 hematological parameters 61 decitabine 61 RAPAFLO 61 mL/min/#.# m 2 61 TAXUS Stent 61 ER CHOP 61 Celebrex celecoxib 61 dose melphalan 61 Glucophage metformin 61 TEAEs 61 pheochromocytoma 61 Acute myeloid leukemia 61 GISTs 61 XGEVA 61 malignancy HCM 61 Darusentan 61 SCCHN 61 pharmacokinetic interactions 61 inhaled iloprost 61 advanced adenomas 61 receiving XGEVA 61 bisoprolol 61 Epratuzumab 61 dosing cohort 61 elevated ALT 61 INTEGRILIN R 61 CHAMPION PCI 61 receiving VICTRELIS 61 weekly subcutaneous injections 61 imiquimod cream 61 AVONEX ® 61 Antitumor Activity 61 peginterferon alfa 2a 61 cilengitide 61 tinidazole 61 INTELENCE 61 Certican 61 Diovan HCT 61 dose dabigatran 61 unresectable tumors 61 Fluconazole 61 VEGF inhibition 61 tamsulosin 61 IFN α 61 5 fluorouracil leucovorin 61 HMG CoA reductase inhibitor 61 UPLYSO